Bergapten Alleviates Periodontitis by Suppressing NLRP3 Inflammasome Activation via Mitophagy-Induced Disruption of NEK7-NLRP3 Interaction.
6 affiliations
- 1Key Laboratory of Shaanxi Province for Craniofacial Precision Medicine Research, College of Stomatology, Xi'an Jiaotong University, Xi'an 710004, China.
- 2Clinical Research Center of Shaanxi Province for Dental and Maxillofacial Diseases, College of Stomatology, Xi'an Jiaotong University, Xi'an 710004, China.
- 3Department of Urology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.
- 4Key Laboratory for Tumor Precision Medicine of Shaanxi Province, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.
- 5Engineering Research Center of Tibetan Medicine Detection Technology, Ministry of Education, School of Medicine, Xizang Minzu University, Xianyang 712082, China.
- 6Department of Implant Dentistry, College of Stomatology, Xi'an Jiaotong University, Xi'an 710004, China.
Abstract
Periodontitis is a prevalent chronic inflammatory disease characterized by gingival inflammation and progressive alveolar bone loss. The NLRP3 inflammasome functions as a molecular mediator that drives its pathogenesis. Bergapten (BeG), a natural furanocoumarin, exhibits anti-inflammatory properties and bone-protective effects. This study demonstrates that BeG alleviates experimental periodontitis in mice by inhibiting the NLRP3 inflammasome. Mechanistically, BeG does not affect NLRP3 priming, dispersed trans-Golgi network (dTGN) localization, or oligomerization; instead, it induces mitophagy by inhibiting the AKT-mTOR axis and consequently suppresses the mtROS-dependent NEK7-NLRP3 interaction. Notably, BeG also suppressed cytosolic release of oxidized mitochondrial DNA (ox-mtDNA), a known endogenous ligand for NLRP3. This effect was attributed to BeG-mediated inhibition of NLRP3 activation, likely via blockade of GSDMD-NT mitochondrial localization. These findings deepen our understanding of the anti-inflammatory mechanisms of BeG and position it as a promising candidate for periodontitis treatment.
Related
- The Lysine Methyltransferase SETDB1 Alleviates Methionine- and Choline-Deficient Diet-Induced Steatohepatitis by Suppressing Ferroptosis
- Spermine Alleviates Chondrocyte Senescence and Extracellular Matrix Degradation by Suppressing NF-κB Signaling, with Odc1 Acting as a Potential Upstream Regulator
- An Oxidized Mogrol Derivative Alleviates LPS-Induced Acute Lung Injury in Association with Reduced NLRP3 Inflammasome-Associated Inflammatory Responses in Mice
- Interleukin-38 promotes alveolar bone repair in periodontitis by suppressing the nuclear factor kappa B pathway
- Molecular mechanisms of NLR proteins in inflammasome activation
BibTeX
@article{jia2026bergapten,
title = {{Bergapten Alleviates Periodontitis by Suppressing NLRP3 Inflammasome Activation via Mitophagy-Induced Disruption of NEK7-NLRP3 Interaction.}},
author = {Xiangbin Jia and Yuzhao Wang and Jiao Cao and Lifei Pan and Xiaoxuan Cui and Hanxue Shan and Yiqing Wang and Xiao Cao and Qin Zhou},
journal = {Antioxidants (Basel, Switzerland)},
year = {2026},
month = oct,
doi = {10.3390/antiox15101304},
url = {https://europepmc.org/article/MED/42939878},
note = {CC BY},
}
RIS
TY - JOUR
TI - Bergapten Alleviates Periodontitis by Suppressing NLRP3 Inflammasome Activation via Mitophagy-Induced Disruption of NEK7-NLRP3 Interaction.
AU - Xiangbin Jia
AU - Yuzhao Wang
AU - Jiao Cao
AU - Lifei Pan
AU - Xiaoxuan Cui
AU - Hanxue Shan
AU - Yiqing Wang
AU - Xiao Cao
AU - Qin Zhou
PY - 2026
DA - 2026/10/09
JO - Antioxidants (Basel, Switzerland)
DO - 10.3390/antiox15101304
UR - https://europepmc.org/article/MED/42939878
AB - Periodontitis is a prevalent chronic inflammatory disease characterized by gingival inflammation and progressive alveolar bone loss. The NLRP3 inflammasome functions as a molecular mediator that drives its pathogenesis. Bergapten (BeG), a natural furanocoumarin, exhibits anti-inflammatory properties and bone-protective effects. This study demonstrates that BeG alleviates experimental periodontitis in mice by inhibiting the NLRP3 inflammasome. Mechanistically, BeG does not affect NLRP3 priming, dispersed trans-Golgi network (dTGN) localization, or oligomerization; instead, it induces mitophagy by inhibiting the AKT-mTOR axis and consequently suppresses the mtROS-dependent NEK7-NLRP3 interaction. Notably, BeG also suppressed cytosolic release of oxidized mitochondrial DNA (ox-mtDNA), a known endogenous ligand for NLRP3. This effect was attributed to BeG-mediated inhibition of NLRP3 activation, likely via blockade of GSDMD-NT mitochondrial localization. These findings deepen our understanding of the anti-inflammatory mechanisms of BeG and position it as a promising candidate for periodontitis treatment.
SN - 2076-3921
ER -